| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EW | Common Stock | Award | $0 | +4.66K | +27.55% | $0.00 | 21.6K | May 7, 2024 | Direct | F1 |
| transaction | EW | Common Stock | Award | $0 | +2.9K | +13.44% | $0.00 | 24.5K | May 7, 2024 | Direct | F1 |
| transaction | EW | Common Stock | Options Exercise | $31.5K | +857 | +3.5% | $36.75* | 25.3K | May 7, 2024 | Direct | F2 |
| transaction | EW | Common Stock | Tax liability | -$49.9K | -586 | -2.31% | $85.09 | 24.7K | May 7, 2024 | Direct | |
| transaction | EW | Common Stock | Sale | -$73.4K | -857 | -3.46% | $85.60 | 23.9K | May 7, 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EW | Employee Stock Option (Right to Acquire) | Award | $0 | +15.5K | $0.00 | 15.5K | May 7, 2024 | Common Stock | 15.5K | $85.84 | Direct | F3 | |
| transaction | EW | Employee Stock Option (Right to Acquire) | Options Exercise | $0 | -857 | -100% | $0.00* | 0 | May 7, 2024 | Common Stock | 857 | $36.75 | Direct | |
| transaction | EW | Performance Rights | Award | $0 | +2.9K | $0.00 | 2.9K | May 7, 2024 | Common Stock | 2.9K | Direct | F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| F2 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023. |
| F3 | These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| F4 | Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.